Home › Funds › Andera Partners › ABVX

Andera Partners position in ABVX

ABIVAX SA ADR · Health Care

Andera Partners reported holding 78,125 shares of ABVX (ABIVAX SA ADR) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 5.04% of its reported portfolio and ranking #7 among its reported holdings. Andera Partners first reported this position in Q2 2026.

Latest position (Q2 2026)78.12K sh
Reported value held$10.41M
Portfolio Weight5.04%
First reportedQ2 2026
Last changeNew

How Andera Partners's ABVX position evolved

Andera Partners first disclosed a stake in ABVX in Q2 2026 at 78,125 shares (US$10.4M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 78.12K $10.41M New

About ABVX and 13F data

ABVX (ABIVAX SA ADR) is a Health Care company. 250 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →